COVID-19 vaccine testing & administration guidance for allergists/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI).

导出 OA

翻译打印收藏纠错

作者： Timothy K,Vander Leek ^[1] ; Edmond S,Chan ^[2] ; Lori,Connors ^[3] ; Beata,Derfalvi ^[4] ; Anne K,Ellis ^[5] ; Julia E M,Upton ^[6] ; Elissa M,Abrams ^[7]

作者单位： Pediatric Allergy and Asthma, Department of Pediatrics, University of Alberta, 207-10430 61 Ave NW, Edmonton, AB, T6H 2J3, Canada. tim.vanderleek@ualberta.ca. ^[1] Division of Allergy and Immunology, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada. ^[2] Department of Medicine, Dalhousie University, Halifax, NS, Canada. ^[3] Division of Immunology, Department of Pediatrics, Dalhousie University/IWK Health Centre, Halifax, NS, Canada. ^[4] Division of Allergy & Immunology, Department of Medicine, Queen's University, Kingston, ON, Canada. ^[5] Division of Immunology and Allergy, Hospital for Sick Children, Department of Paediatrics, University of Toronto, Toronto, ON, Canada. ^[6] Department of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, Winnipeg, MN, Canada. ^[7] Department of Pediatrics, Division of Allergy and Immunology, University of British Columbia, Vancouver, BC, Canada. ^[8]

关键词 Allergy Anaphylaxis COVID-19 Immune deficiency Immunocompromise PEG Vaccine

DOI 10.1186/s13223-021-00529-2

PMID 33722299

发布时间 2023-11-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交